Evaluation of the ReVive SE Device for Intra-Arterial Thrombectomy in Acute Ischemic Stroke "Re-ACT"

Completed

Phase N/A Results N/A

Trial Description

The main objective of this study is to assess the safety and effectiveness of the ReVive SE (Self- Expanding) Neurothrombectomy Device in subjects requiring mechanical thrombectomy when used according to its Instruction for use (IFU).

Conditions

Trial Design

  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Trial Population

subjects requiring mechanical thrombectomy

Outcomes

Type Measure Time Frame Safety Issue
Primary modified Rankin Scale 90 days Yes
Secondary National Institute of Health Stroke Scale (NIHSS) 90 days Yes
Secondary National Institute of Health Stroke Scale (NIHSS) 90 days Yes

Sponsors